GSK Appoints Sanofi Veteran to Lead Vaccines R&D; Leadership Change at Bristol Myers Corporate Affairs

on

GSK has hired Sanjay Gurunathan, a veteran executive from Sanofi, to head its vaccines and infectious disease R&D unit as the company addresses ongoing challenges in the sector1.

This leadership change follows GSK’s continued focus on pipeline productivity and the development of 14 key pipeline opportunities expected to launch between 2025 and 2031, each with peak year sales potential of over £2 billion2.

Sanofi has also made a high-profile hire, bringing in Chris Corsico from GSK to serve as its global head of development, further highlighting recent cross-movements in pharmaceutical R&D leadership roles35.

No direct information regarding a new corporate affairs head at Bristol Myers Squibb was found in the provided search results.

Sources:

1. https://firstwordpharma.com/story/5970199

2. https://www.gsk.com/media/11972/q1-2025-results-transcript.pdf

3. https://www.fiercebiotech.com/biotech/sanofi-snags-gsks-chris-corsico-serve-global-head-development

5. https://www.thepharmaletter.com/pharmaceutical/sanofi-names-gsks-chris-corsico-as-new-development-head